FDA issued a Warning Letter to Glenmark Pharmaceuticals Limited on 10/3/2019 for a later inspection.
483 Glenmark Pharmaceuticals May 2015

483 Glenmark Pharmaceuticals May 2015

Linda Murphy FDA, Liming Zhang FDA$119.00 - Available Now

FDA investigators audited the Glenmark Pharmaceuticals - Solan, India facility and issued 5 inspectional observations (via FDA 483) on 29 May 2015.

Product details

  • Category: Human Drugs
  • Number of Observations: 5
  • Inspection end: 29 May 2015
  • Location: Solan, India
  • FEI: 3005757050
Add To Cart